BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21114854)

  • 1. Reduction of novel circulating long-chain fatty acids in colorectal cancer patients is independent of tumor burden and correlates with age.
    Ritchie SA; Heath D; Yamazaki Y; Grimmalt B; Kavianpour A; Krenitsky K; Elshoni H; Takemasa I; Miyake M; Sekimoto M; Monden M; Tomonaga T; Matsubara H; Sogawa K; Matsushita K; Nomura F; Goodenowe DB
    BMC Gastroenterol; 2010 Nov; 10():140. PubMed ID: 21114854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolome Analysis of Human Serum: Implications for Early Detection of Colorectal Cancer].
    Yamazaki Y
    Rinsho Byori; 2015 Mar; 63(3):328-35. PubMed ID: 26524856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-serum GTA-446 anti-inflammatory fatty acid levels as a new risk factor for colon cancer.
    Ritchie SA; Tonita J; Alvi R; Lehotay D; Elshoni H; Myat S; McHattie J; Goodenowe DB
    Int J Cancer; 2013 Jan; 132(2):355-62. PubMed ID: 22696299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
    Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers.
    Ivancic MM; Megna BW; Sverchkov Y; Craven M; Reichelderfer M; Pickhardt PJ; Sussman MR; Kennedy GD
    J Surg Res; 2020 Feb; 246():160-169. PubMed ID: 31586890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
    Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
    Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
    Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
    Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
    Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
    Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
    Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Benner A; Schrotz-King P; Brenner H
    Mol Oncol; 2020 Jan; 14(1):8-21. PubMed ID: 31652396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
    Song EM; Byeon JS; Lee SM; Yoo HJ; Kim SJ; Lee SH; Chang K; Hwang SW; Yang DH; Jeong JY
    Dig Dis Sci; 2018 May; 63(5):1229-1236. PubMed ID: 29516324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
    Wang DS; Zhong B; Zhang MS; Gao Y
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study.
    Wei SC; Tsao PN; Wang YT; Lin BR; Wu DC; Tsai WS; Chen JS; Wong JM
    Cancer Med; 2019 Jul; 8(7):3583-3591. PubMed ID: 31063258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
    Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
    Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
    Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
    Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.
    Rahier JF; Druez A; Faugeras L; Martinet JP; Géhénot M; Josseaux E; Herzog M; Micallef J; George F; Delos M; De Ronde T; Badaoui A; D'Hondt L
    Clin Epigenetics; 2017; 9():53. PubMed ID: 28515797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.